Saikosaponin B2

Product Specifications

CAS Number

58316-41-9

Target

HCV Protease

Related Pathways

Microbiology/Virology|||Proteases/Proteasome

Purity

0.9988

Bioactivity

Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 ?M) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis.

Smiles

[H][C@@]1(O[C@H]2[C@@H](O)[C@@H](C)O[C@@]([H])(O[C@H]3CC[C@@]4(C)[C@@]([H])(CC[C@]5(C)[C@]4([H])C=CC4=C6CC(C)(C)CC[C@]6(CO)[C@H](O)C[C@@]54C)[C@]3(C)CO)[C@@H]2O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O